Anaplastic giant-cell carcinoma of the thyroid.A study of treatment and prognosis
- 1 May 1975
- Vol. 35 (5), 1293-1295
- https://doi.org/10.1002/1097-0142(197505)35:5<1293::aid-cncr2820350504>3.0.co;2-w
Abstract
In 79 cases of histologically verified anaplastic giant-cell carcinoma, symptoms, treatment, and prognosis were documented. Seventy-eight patients are dead, the mean survival time being 2.5 months. One patient is cured. It was concluded that surgery and/or radiotherapy alone are not sufficient. The results from an additional 8 patients also treated with methotexate indicate a positive therapeutic effect, the mean survival time being 9.4 months. Disappearance of recurrent tumor or pulmonary metastases was noted in 2 patients.This publication has 6 references indexed in Scilit:
- Treatment of squamous cell carcinoma of the head and neck with combined methotrexate and irradiationCancer, 1970
- Anaplastic tumors of the thyroidCancer, 1969
- Thyroid carcinoma—Biologic behavior and mortality:Postmortem findings in 42 cases, including 27 in which the disease was fatalCancer, 1966
- RADIATION THERAPY IN THE CONTROL OF PERSISTENT THYROID CANCERAmerican Journal of Roentgenology, 1966
- Intra-arterial chemotherapy and X-ray therapy in cancer of the head and neckClinical Radiology, 1963
- The Results of X-Ray Treatment in Undifferentiated Carcinoma of the ThyroidRadiology, 1961